Normalization of liver enzymes in an HIV-hepatitis C virus-co-infected patient after potent antiretroviral therapy [3]

AIDS

Volumn 16, Issue 8, 2002, Pages 1193-

  Diaz, Beatriz ^a   Martín Carbonero, Luz ^a   Pérez Olmeda, Mayte ^a   Soriano, Vincent ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EFAVIRENZ; LAMIVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG POTENCY; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0037165928     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200205240-00018     Document Type: Letter

References (3)

1. Resolution of chronic hepatitis B after ritonavir treatment in an HIV-infected patient
2. Liver damage and kinetics of HCV and HIV replication during the early phases of combination antiretroviral treatment
3. Evolution of coinfection with HIV and HCV in patients treated with HAART